TOP NEWS

BioForm Files For IPO

San Mateo-based BioForm, a provider of a dermal filler product for medical aesthetics. has filed for an IPO. The firm, in a filing with the SEC, said that it is looking to raise up to $115M in an IPO on the Nasdaq Global Market under the symbol "BFRM." The firm's IPO is being underwritten by JPMorgan, Piper Jaffray, CIBC World Markets, and Jeffries & Company. The firm reported in its SEC filing that it had a loss of $13.5M on revenues of $47.4M in the year ending June 30, 2007. BioInform is venture backed by Essex Woodlands Health Ventures, PTV Sciences, Vivo Ventures, Teknoinvest, and others.


LATEST HEADLINES

More Headlines

BROWSE ISSUES